You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 1, January 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (6)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Diabetic Retinopathy
 •Alert me on articles by topic

Effect of Perioperative Glycemic Control in Progression of Diabetic Retinopathy and Maculopathy

Chikako Suto, MD; Sadao Hori, MD; Satoshi Kato, MD; Kanemitsu Muraoka, MD; Shigehiko Kitano, MD

Arch Ophthalmol. 2006;124:38-45.

Objective  To evaluate the contribution of perioperative glycemic control to progression of diabetic retinopathy and maculopathy.

Methods  Postoperative progression of diabetic retinopathy and maculopathy were compared in 87 patients with type 2 diabetes mellitus who underwent monocular phacoemulsification cataract surgery performed by a single surgeon. Twenty-seven patients had had poor glycemic control preoperatively and underwent rapid preoperative glycemic correction; 30 patients had poor control preoperatively that was not corrected postoperatively; and 30 patients had good preoperative glycemic control. The grade of diabetic retinopathy and maculopathy in the operated-on eye and the fellow eye was assessed preoperatively and for 12 months postoperatively.

Results  There were no significant differences in the progression rate of diabetic retinopathy among the 3 groups (P = .27). However, the progression rate of diabetic maculopathy was significantly higher in the group that underwent rapid control than in the other 2 groups (P = .02). Patients with moderate to severe nonproliferative diabetic retinopathy preoperatively in the rapid control group had significantly higher progression rates of diabetic retinopathy and maculopathy (P = .002 and .008, respectively).

Conclusions  Rapid preoperative glycemic control should be avoided in patients with moderate to severe nonproliferative diabetic retinopathy because it may increase the risk of postoperative progression of retinopathy and maculopathy.


Author Affiliations: Department of Ophthalmology (Drs Suto and Hori) and Diabetes Center (Dr Kitano), Tokyo Women’s Medical University, Tokyo, Japan; and Departments of Ophthalmology, University of Tokyo School of Medicine, Tokyo (Dr Kato), and Hidaka Hospital, Takasaki, Japan (Dr Muraoka).


RELATED LETTERS

Perioperative Glycemic Control and Diabetic Retinopathy
Haytham I. S. Salti, Johnny K. Khoury, and Sandra Haddad
Arch Ophthalmol. 2007;125(4):577-578.
EXTRACT | FULL TEXT  

Perioperative Glycemic Control and Diabetic Retinopathy—Reply
Chikako Suto, Sadao Hori, and Satoshi Kato
Arch Ophthalmol. 2007;125(4):578.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Perioperative Glycemic Control and Diabetic Retinopathy--Reply
Suto et al.
Arch Ophthalmol 2007;125:578-578.
FULL TEXT  

Perioperative Glycemic Control and Diabetic Retinopathy
Salti et al.
Arch Ophthalmol 2007;125:577-578.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.